Insulin sensitisation affects lipoprotein lipase transport in type 2 diabetes: Role of adipose tissue and skeletal muscle in response to rosiglitazone

Diabetologia

Volumn 49, Issue 10, 2006, Pages 2412-2418

  Tan, G D ^a   Olivecrona, G ^b   Vidal, H ^c   Frayn, K N ^a   Karpe, F ^d  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UMEÅ UNIVERSITY   (Sweden)

^c UNIVERSITÉ LYON 1   (France)

^d CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

Lipases; Thiazolidinedione; Very low density lipoprotein

Indexed keywords

LIPOPROTEIN LIPASE; MESSENGER RNA; PLACEBO; ROSIGLITAZONE; TRIACYLGLYCEROL;

ADIPOSE TISSUE; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSE RESPONSE; DRUG MECHANISM; FEMALE; FOREARM BLOOD FLOW; HUMAN; IN VIVO STUDY; INSULIN SENSITIVITY; MALE; MUSCLE BIOPSY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN METABOLISM; PROTEIN TRANSPORT; SKELETAL MUSCLE;

ADIPOSE TISSUE; BINDING SITES; BIOLOGICAL TRANSPORT; DIABETES MELLITUS, TYPE 2; ENDOTHELIUM, VASCULAR; HUMANS; INSULIN; KINETICS; LIPOPROTEIN LIPASE; MUSCLE, SKELETAL; RNA, MESSENGER; THIAZOLIDINEDIONES;

EID: 33748516743     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-006-0370-9     Document Type: Article

References (27)

1. Simsolo RB, Ong JM, Saffari B, Kern PA (1992) Effect of improved diabetes control on the expression of lipoprotein lipase in human adipose tissue. J Lipid Res 33:89-95
2. Taskinen MR, Nikkila EA, Kuusi T, Harmo K (1982) Lipoprotein lipase activity and serum lipoproteins in untreated type 2 (insulin-independent) diabetes associated with obesity. Diabetologia 22:46-50
3. Taskinen MR, Nikkila EA, Nousiainen R, Gordin A (1981) Lipoprotein lipase activity in adipose tissue and skeletal muscle of human diabetics during insulin deprivation and restoration. Scand J Clin Lab Invest 41:263-268
4. Nikkila EA, Huttunen JK, Ehnholm C (1977) Postheparin plasma lipoprotein lipase and hepatic lipase in diabetes mellitus. Relationship to plasma triglyceride metabolism. Diabetes 26:11-21
5. Miyashita Y, Shirai K, Itoh Y et al (2002) Low lipoprotein lipase mass in preheparin serum of type 2 diabetes mellitus patients and its recovery with insulin therapy. Diabetes Res Clin Pract 56:181-187
6. Hanyu O, Miida T, Obayashi K et al (2004) Lipoprotein lipase (LPL) mass in preheparin serum reflects insulin sensitivity. Atherosclerosis 174:385-390
7. Bengtsson-Olivecrona G, Olivecrona T (1992) Assay of lipoprotein lipase and hepatic lipase. Oxford University Press, Oxford, pp 170-184
8. Miyashita Y, Shirai K (2005) Clinical determination of the severity of metabolic syndrome: preheparin lipoprotein lipase mass as a new marker of metabolic syndrome. Curr Med Chem Cardiovasc Hematol Agents 3:377-381
9. Rip J, Nierman MC, Wareham NJ et al (2006) Serum lipoprotein lipase concentration and risk for future coronary artery disease. The EPIC-Norfolk Prospective Population Study. Arterioscler Thromb Vasc Biol 26:637-642
10. Merkel M, Eckel RH, Goldberg IJ (2002) Lipoprotein lipase: genetics, lipid uptake, and regulation. J Lipid Res 43:1997-2006
11. Mead JR, Irvine SA, Ramji DP (2002) Lipoprotein lipase: structure, function, regulation, and role in disease. J Mol Med 80:753-769
12. Wu G, Brouckaert P, Olivecrona T (2004) Rapid downregulation of adipose tissue lipoprotein lipase activity on food deprivation: evidence that TNF-alpha is involved. Am J Physiol Endocrinol Metab 286:E711-E717
13. Ong JM, Kern PA (1989) Effect of feeding and obesity on lipoprotein lipase activity, immunoreactive protein, and messenger RNA levels in human adipose tissue. J Clin Invest 84:305-311
14. Bergo M, Wu G, Ruge T, Olivecrona T (2002) Down-regulation of adipose tissue lipoprotein lipase during fasting requires that a gene, separate from the lipase gene, is switched on. J Biol Chem 277:11927-11932
15. Wu G, Olivecrona G, Olivecrona T (2005) Extracellular degradation of lipoprotein lipase in rat adipose tissue. BMC Cell Biol 6:4
16. Ruge T, Bergo M, Hultin M, Olivecrona G, Olivecrona T (2000) Nutritional regulation of binding sites for lipoprotein lipase in rat heart. Am J Physiol Endocrinol Metab 278:E211-E218
17. Karpe F, Olivecrona T, Olivecrona G et al (1998) Lipoprotein lipase transport in plasma: the role of muscle and adipose tissue in regulation of plasma lipoprotein lipase concentrations. J Lipid Res 39:2387-2393
18. Tan GD, Fielding BA, Currie JM et al (2005) The effects of rosiglitazone on fatty acid and triglyceride metabolism in type 2 diabetes. Diabetologia 48:83-95
19. Frayn KN, Coppack SW (2001) Assessment of white adipose tissue metabolism by measurement of arteriovenous differences. Methods Mol Biol 155:269-279
20. Holm C, Olivecrona G, Ottosson M (2001) Assays of lipolytic enzymes. Methods Mol Biol 155:97-119
21. Tornvall P, Olivecrona G, Karpe F, Hamsten A, Olivecrona T (1995) Lipoprotein mass and activity in plasma and their increase after heparin are separate parameters with different relations to plasma lipoproteins. Arterioscler Thromb Vasc Biol 15:1086-1093
22. Eriksson JW, Buren J, Svensson M, Olivecrona T, Olivecrona G (2003) Postprandial regulation of blood lipids and adipose tissue lipoprotein lipase in type 2 diabetes patients and healthy control subjects. Atherosclerosis 166:359-367
23. Lookene A, Savonen R, Olivecrona G (1997) Interaction of lipoproteins with heparan sulfate proteoglycans and with lipoprotein lipase. Studies by surface plasmon resonance technique. Biochemistry 36:5267-5275
24. Lookene A, Zhang L, Hultin M, Olivecrona G (2004) Rapid subunit exchange in dimeric lipoprotein lipase and properties of the inactive monomer. J Biol Chem 279:49964-49972
25. Reizes O, Goldberger O, Smith AC, Xu Z, Bernfield M, Bickel PE (2006) Insulin promotes shedding of syndecan ectodomains from 3T3-L1 adipocytes: a proposed mechanism for stabilization of extracellular lipoprotein lipase. Biochemistry 45:5703-5711
26. Shirai K, Itoh Y, Sasaki H et al (1999) The effect of insulin sensitizer, troglitazone, on lipoprotein lipase mass in preheparin serum. Diabetes Res Clin Pract 46:35-41
27. Nagashima K, Lopez C, Donovan D et al (2005) Effects of the PPARgamma agonist pioglitazone on lipoprotein metabolism in patients with type 2 diabetes mellitus. J Clin Invest 115:1323-1332